A Challenge to Science and Nature
A Challenge to Science and Nature
A new journal will challenge publishing behemoths such as Science, Nature and Cell by offering free access to research articles immediately upon publication on the Web.
Life after Venter
Life after Venter
At Celera Genomics, a new president and questions about the company’s direction.
Biotech heads west for VC
Biotech heads west for VC
The pot of gold to fund biotech research in Memphis may come from Little Rock
Cloning Bill Bans Abortion Too?
Cloning Bill Bans Abortion Too?
Cloning and abortion — separate issues altogether, right? Maybe not. There are those who believe that if cloning is outlawed, then abortion will be too.
Biotech Banker Predicts More Meetings But Fewer Attendees
Biotech Banker Predicts More Meetings But Fewer Attendees
It’s tougher and tougher for people to figure out what’s the right venue for them, for whatever they’re trying to accomplish…
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments